Clinical Trials
2 trialsNCT06058377 2026-05-27
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT03233191 2026-05-05
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting